February 12th, 2013

Janssen Scientists Challenge Industry to Create Integrated Approaches to Healthcare Innovation

We’re pleased to share the news that a group of scientists and business leaders from our Janssen team, along with a professor from the Harvard Business School, co-authored a new commentary in the February issue of the journal Nature Reviews Drug Discovery that addresses integrated approaches to healthcare solutions. Husseini Manji, Global Head of Neuroscience at Janssen Research & Development and Michael Yang, President of Janssen Pharmaceuticals, Inc. are two of the Janssen authors.

The authors challenge the healthcare industry to expand its thinking beyond product-focused, “magic bullet” drug development and discuss the need for an integrated approach to patient care, including use of devices, tools and services to help a patient’s progress. They discuss, for example, how people with serious mental illnesses, such as schizophrenia, are more likely to have better outcomes when they are involved in integrated care plans that involve more than a therapeutic and they look to a future when novel devices will help track and analyze patients’ progress.

This commentary, “Beyond magic bullets: true innovation in health care,” was published in the February 2013 issue of Nature Reviews Drug Discovery and is available here.

Read More

January 23rd, 2013

Neglected Tropical Diseases – Not Neglected by Johnson & Johnson

By: Steven A. Silber, MD, Compound Developer Team Leader, Flubendazole

One of the things that make me proud to be a Johnson & Johnson employee is the commitment and dedication of every person here to do the best we can for patients…especially for the world’s most disadvantaged. I am grateful to be leading the team working to more effectively treat lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), two of the most debilitating tropical diseases in the developing world.

To quote a new report from Uniting to Combat NTDs, an initiative with which J&J is affiliated, neglected tropical diseases (NTDs) are “a group of infectious diseases that disproportionally affect the world’s poorest and most vulnerable populations. It is estimated that more than one billion people are affected by NTDs, including roughly 800 million children. Although these diseases are the most common infections amongst the world’s poorest, they have traditionally received little or inconsistent attention on international health agendas. Targeted commitments and investments from a range of partners over the years have reduced the burden of many NTDs, but significant gaps still remain.”

In January of last year, Johnson & Johnson committed to collaborating with public and private partners to eliminate or control 10 NTDs by 2020, in what are the largest coordinated actions to date in support of the World Health Organization’s NTD goals.

Read More

January 10th, 2013

We All Have an Opportunity to Make a Difference

By Sarah Colamarino, Vice President, Equity Programs

Sometimes in our careers, we have the fortunate opportunity to make a meaningful difference in society through our work.  Over the past 2 years, I have had a unique opportunity to use my background in communications and marketing to work hand-in-hand with my colleagues in Corporate Contributions and together, we are finding ways to involve our customers, fans and friends in causes that Johnson & Johnson has cared about for many years.

Much of our work focuses on helping women and children around the world.  Making a difference is sometimes as simple as using mobile technology to spread critical health information to new and expectant mothers through our text4baby and MAMA initiatives.  Or providing clean water to global communities, ensuring the health and safety of the most vulnerable people. Or raising funds for fistula surgeries, freeing women from the isolation and stigma resulting from obstetric fistula caused by prolonged and often unattended labor. Whatever the cause – the need is great and sometimes even a small gesture can make an important difference.

To celebrate the recent holiday season, we launched a program with Catapult.org that channels the generosity of those who want to help towards the organizations that most need support.  Catapult offers an initiative approach to fund raising for multiple organizations impacting women and children.  Through the end of January, Johnson & Johnson will match individual contributions to specific projects dollar for dollar up to $50,000. We encourage you to think about making a special contribution for yourself or consider a gift in the name of a family member or friend.

Read More

January 2nd, 2013

Ten Days in Kenya: A Johnson & Johnson Employee Gives Back

Happy New Year to our blog readers!  We’re kicking off 2013 by sharing a story about one of our employees, Melissa Katz, and her journey to Kenya to volunteer with the WISER school for girls.

Here’s what Melissa has to say:

The people who work at Johnson & Johnson are a special breed. We take our responsibilities seriously. “We have a responsibility to the communities in which we live and work and to the world community as well.” These are not just words on a page. We live it. We offer days off for volunteerism for employees to contribute to their community. Where and for what cause we volunteer is up to us.

Dr. Sherryl Broverman from Duke University tells us that if you want to end poverty, prevent disease, end hunger there is a one-size-fits-all solution:  Educate a girl.  I am a well educated woman. It wasn’t even a question that I would go to school past age 13 and then go to college. That is far from the situation in Muhuru Bay, Kenya.

Melissa will be blogging about her journey at www.educateagirl.blogspot.com. We hope you’ll follow along.

Read More

December 20th, 2012

mHealth Summit 2012

by Susan Rucci, Johnson & Johnson NYU Global Fellow

Recently, I had the opportunity to be a part of the Johnson & Johnson team at the 4th annual mHealth Summit 2012 in Washington, D.C.  Johnson & Johnson was a sponsor of the summit which highlighted emerging best practices for mobile health research and implementation.  To me, the conference was an indication of a health care renaissance around mobile health technology that is leading to smarter ways of educating, treating and preventing diseases.  It was also a great way for Johnson & Johnson to demonstrate our commitment to helping people around the world live longer, healthier, happier lives.

We believe in the potential of mobile technology to revolutionize the delivery of health information and healthcare and we were proud to showcase several of our mHealth innovations and partnerships that are making that potential a new reality for millions of people around the world.

Here are a few examples:

DIGITAL HEALTH SCORECARD:

Conference attendees got a chance to try out our newly launched Johnson & Johnson Digital Health Scorecard. heath_care_information

The scorecard is like a credit score for your health.  It asks seven simple questions about health measures and habits and delivers a single number (based out of 100.)  The number indicates where you currently stand and what you can do to lessen the long term risk of developing chronic diseases such as diabetes, cancer and heart disease.  According to the World Health Organization, 3 in 5 deaths worldwide are now from chronic health diseases.  By 2020, that number will likely rise to 3 in 4 deaths if behavior modifications don’t happen now.

Read More

November 21st, 2012

JNJ Spends Thanksgiving by Giving Back

by Patrick McCrummen, Director of Worldwide Corporate Contributions at Johnson & Johnson

On Thursday, many people in the U.S. will give collective thanks over a shared meal with family and friends on Thanksgiving Day.  Yet, for many people along the U.S. eastern seaboard, struggles remain to return to normal after one of the most devastating hurricanes ever to hit the region. After witnessing the worst of Mother Nature, the best of humankind has come together, helping neighbors and communities get back on their feet.

New Jersey residents were particularly hard hit by this ferocious storm.  More than 13,800 of our employees live and work in this state – where our company has called home for more than 125 years.  For the many who were impacted, the Johnson & Johnson legacy of helping people recover from disaster became very personal.

In the critical days and weeks following Hurricane Sandy, Johnson & Johnson has been working with our key disaster response partners to get product and financial assistance to people in need in New Jersey, New York and Pennsylvania.  Thousands of our hygiene kits, first aid items and Johnson® Baby Care kits were distributed to emergency shelters and aid distribution centers by AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, Inc.

Read More

November 13th, 2012

Life for a Child: A Year in the Life of a Contribution.

In recognition of World Diabetes Day, the Johnson & Johnson Family of Diabetes Companies made an announcement yesterday about a commitment from LifeScan, Inc.to supply one million test strips and encourage support for International Diabetes Federation’s “Life for a Child”  program.

Following is a blog post from Charles Renfroe, Director of Diabetes Advocacy & Alliances, Johnson & Johnson Family of Diabetes Companies, about the program.

life_for_a_child

 

 

 

 

On Wednesday, November 14, the world commemorates World Diabetes Day on the birthday of Frederick Banting, who discovered insulin more than 90 years ago. While a cure for type 1 diabetes (T1D) continues to elude us for the time being, no one denies that technological advances since the discovery of insulin in 1921 have saved countless lives and made life better and easier for those who not only survive, but thrive with T1D. While research and development continue to bring life-saving technologies and medicines to market, the importance of making essential medicines, especially insulin, widely available to those who need them around the world, cannot be underestimated.

Thousands of children in the developing world are suffering and facing death because they do not have access to treatment. One small but growing program of the International Diabetes Federation (IDF) is working tirelessly to save the children of the world who are living with T1D. Life for a Child, with the help of grants, corporate support and individual donations, distributes life-saving insulin to 10,000 children in 39 developing countries around the world.

Read More

November 6th, 2012

Recovering From Hurricane Sandy

by Alex Gorsky, CEO of Johnson & Johnson

Johnson & Johnson extends our heartfelt sympathy to all those who have been affected by Hurricane Sandy.  We have been deeply committed to the New Jersey, Pennsylvania and New York region for more than 125 years.  And today, we remain focused and united in helping people and communities stabilize and return to normal in the aftermath of this unprecedented natural disaster.

Following are some examples of the ways we’re helping care for our customers, our communities and our employees:

Supporting our customers

Against difficult odds, employees throughout North America have been working to ensure that our customers have the products they need. Whether they are in distribution centers or the field, Johnson & Johnson employees have worked tirelessly to supply hospitals, pharmacies and retailers with what their patients and customers need.

We continue to assess potential customer needs for all of our products — medicines, medical devices, consumer healthcare, first aid, etc.  — and address contingencies to ensure that customers and patient needs are being met in the affected areas and across our global supply chain.

At this point, we have not experienced any supply interruptions and our medical products continue to flow to the customers, patients and health care facilities that need them.

Read More

November 2nd, 2012

LATISM ’12 – Muy Bueno!

We’re back from Houston, y’all!  Last week, we spent two fun and rewarding days at the LATISM ’12 conference in Houston, TX.  We were delighted to return as a sponsor of this conference, and as always, we received a warm and wonderful welcome from the attendees and leaders.  There is a special vibe at LATISM and we are honored to be part of la familia.

Bloggers and visitors, including Jeannette Kaplun (center) learned about our products, our philanthropic programs, and our partners such as Save the Children, Pro Mujer and Text4Baby.

This year, our theme at the conference was about using social media for social good – specifically to support global motherhood.  After arriving in Houston, we started setting up our suite, where attendees came to learn about our philanthropic work to help mothers and babies around the world.  Visitors could view photos in our gallery and read about many of our projects, as well as talk to our partners, Save the Children, Pro Mujer and Text4Baby about their programs.  We also invited visitors to share stories about what inspires them to care and to add a piece to our JOHNSON’S® Baby lotion puzzle.  The comments we received were touching and heartfelt, with many visitors sharing emotional stories and telling us how much they learned about Johnson & Johnson’s work.

Read More

October 29th, 2012

World Psoriasis Day – Celebrating Big Strides in Innovation and Science

By Dan Baker, MD, VP, Immunology Therapeutic Area, Janssen Research & Development, LLC

Today is World Psoriasis Day, an important date established to raise the profile and reduce the stigma that surrounds psoriasis. This day is truly global in its reach — created by, and dedicated to, the 125 million people living with psoriasis and psoriatic arthritis around the world.

Psoriasis is characterized by red, scaly and often itchy patches on the skin. Symptoms can range from mild — a few patches in select areas — to severe, with plaques covering more than 10 percent of the body.

Psoriasis is the most common immune-mediated skin disorder in the world, affecting nearly three percent of the world’s population. But despite the disease’s widespread impact, psoriasis is often misunderstood, and people affected sometimes face public humiliation as a result of their symptoms. Though it is often characterized as a ‘skin condition,’ psoriasis is much more than that – it is an inflammatory disease resulting in increased risk of other severe conditions and even increased morbidity.

That’s why at Janssen, we are committed to making a difference in the lives of people living with psoriasis through ongoing research and bringing forward new treatment options.

Read More